The lack of effect in monkeys following chronic haloperidol administration suggests that the well-documented reductions in pan-BDNF mRNA in humans diagnosed with schizophrenia are due to the illness and not to antipsychotic treatment. The gene discussed is BDNF; the disease is schizophrenia.